Curcumin Supplementation Linked to 54 Percent Reduction in Age-Related Vision Loss Risk
Curcumin Supplementation Linked to 54 Percent Reduction in Age-Related Vision Loss Risk

By Huey Freeman

A new study from the Stanford University College of Medicine has found that a nutritional supplement derived from turmeric significantly reduces the risk of age-related macular degeneration (AMD), the leading cause of vision loss among Americans.

The retrospective cohort study followed nearly 2 million people over 50. It found that people who took curcumin supplements reduced their risk of developing AMD and blindness by more than 50 percent.

“I was surprised by the magnitude of the findings and the risk reduction for patients taking CBNS,” study leader and ophthalmologist Dr. Ehsan Rahimy told The Epoch Times.

Curcuma-based nutritional supplements (CBNS) are infused with curcumin, the active ingredient. Curcumin is derived from the root of Curcuma longa, the scientific name for the turmeric plant. This bright yellow spice, widely used in Indian cuisine, has long been valued in traditional wellness practices.

The study’s findings were published online Thursday in JAMA Ophthalmology.

Macular degeneration affects nearly 20 million Americans and causes approximately 9 percent of blindness worldwide. The condition damages the retina, resulting in blurred central vision. While the study doesn’t suggest that curcumin can reverse existing damage, it shows promise in preventing disease progression.

Largest Study of Its Kind

Although there have been other smaller-scale studies on curcumin and macular degeneration, this was the largest to date. The research team analyzed medical records of over 1.8 million patients from 2003 to 2024. More than 66,000 of them had taken curcumin supplements, while the remainder served as the control group.

According to the researchers, the study’s scale and use of human medical records rather than laboratory or animal studies set it apart from previous research in the field.

The new research found that patients aged 50 and older with a prescription for CBNS reduced their risk of blindness by more than half. More specifically, there was a 77 percent reduction in the risk of dry AMD, a more common and slower-progressing form of the disease, and an 89 percent reduction in advanced dry AMD.

The results also showed a 72 percent reduction in wet AMD, a more severe and rapidly progressing form of the condition.

Rahimy, a specialist in retinal diseases, said he became interested in research on this supplement because many of his patients are exploring alternative medicines and supplements to help mitigate the progression of their disease.

“While research suggests that genetics, age, and smoking play a role in this condition, emerging evidence in recent years has supported that chronic inflammation in the body can also contribute to macular degeneration formation and progression,” said Rahimy, who has authored numerous book chapters and publications on retinal diseases.

“Given that curcumin and turmeric are potent anti-inflammatory agents, as well as possessing antioxidative properties, this made it a logical candidate to explore for potential ocular benefits,” he said.

“Our study, given its scale, helps support some of the existing literature on this topic,” Rahimy said. “Furthermore, we hope that it will inspire additional investigations into the potential benefits of CBNS.”

Curcumin Has Few Adverse Effects

Rahimy has not seen data to suggest that curcumin reverses age-related macular degeneration, but he hopes it may be a valuable tool in preventing the progression of the disease.

The supplement’s safety profile is strong, given its origin as a widely used spice. Turmeric has been used in both food and medicine for over 5,000 years. However, Rahimy notes some important considerations.

“In rare cases, there is a small risk of liver injury while taking this supplement in higher doses,” he said. “If  anyone is planning to take it as a supplement, they should run it by their doctor to make sure there are no contraindications to use at higher dosages.”

However, there are some challenges regarding the use of a supplement containing curcumin.

“It has a relatively poor bioavailability in the body due to a low absorption rate, as it is rapidly metabolized and cleared from the body,” Rahimy said. “Certain formulations of the supplement, for example, if paired together with black pepper, can help to significantly enhance the absorption of curcumin from the gut.”

Consultation with a health care provider is recommended before starting supplementation. Curcumin has also been shown to be effective in various other medicinal applications. “There is a precedent to using CBNS in other fields of medicine, for example, to help with joint health and skeletal muscle soreness and recovery,” Rahimy added.

The Stanford team plans to conduct follow-up studies to confirm the findings.

“We are excited by the enthusiasm surrounding this project, and we hope to follow up with additional studies in the future to further verify these findings,” Rahimy said.


Discover more from USNN World News

Subscribe to get the latest posts sent to your email.

USNN World News Corporation (USNN) USNN World News is a media company consisting of a series of sites specializing in the collection, publication and distribution of public opinion information, local,...